Xencor said on 25 October it chose 400 mcg/kg as the proposed Phase 3 dose for XmAb819 in advanced clear cell renal cell carcinoma, after that dose produced a 45.5% confirmed response rate in 11 evaluable patients, a figure with a wide confidence interval.
Health6 November 20265 min readSources 18
Prime Medicine said on 5 October it had given PM577a, an in-body prime-editing therapy, to a Wilson disease patient in a global Phase 1/2 trial, which it described as the first clinical use of in vivo prime editing.
Health6 November 20263 min readSources 19
Union members at Cleveland Clinic Lutheran Hospital ratified a three-year contract on 8 October, ending a strike that began on 23 September over healthcare costs. The deal includes nearly 11% in wage increases but does not specifically address premiums.
Health6 November 20263 min readSources 12
Bangladesh has reported 202,000 suspected measles cases since mid-March and 1,147 deaths, the World Health Organization says, the world's worst outbreak this year as vaccination coverage fell below the level needed to prevent outbreaks.
Health6 November 20264 min readSources 10
The FDA moved its decision date for Capricor Therapeutics' deramiocel to 22 November from 22 August, after advisers voted 9-3 against the Duchenne muscular dystrophy cardiomyopathy indication and Capricor narrowed its proposed use to upper-limb function.
Health6 November 20264 min readSources 13
New Jersey finalized an average 19.8% increase in 2027 individual-market health insurance rates on Thursday, ahead of open enrollment on 1 November. Nationally, KFF puts the median proposed increase at 15%.
Health6 November 20264 min readSources 33